Quana

Company Overview

Snapshot

Founded in April 2018 by Adi Naali and Zohar Kerem, Quana operates with 1–10 employees. The company has raised $460K across one funding round. In January 2020, Quana was noted for developing an olfactive device for cannabis analysis.

Business overview

Quana develops a decision support platform for medical cannabis, leveraging a special set of sensors, cloud-based big-data algorithms, and a mobile app. The company's core technology generates unique olfactive fingerprints for cannabis samples, identifying molds and pesticides. It also personalizes cannabinoid consumption through decision-making algorithms that match suitable cannabis products to consumer needs. Quana serves consumers, retailers, pharma companies, and healthcare providers within the medical cannabis market.

Strategic signal

In January 2020, Quana was featured for its innovative olfactive device designed for cannabis analysis. This highlights the company's early focus on advanced sensory technology to provide detailed insights into cannabis products, signaling a commitment to precision and personalization in the medical cannabis sector.

Company Intelligence Q&A

What is Quana's primary focus?

Quana focuses on providing a decision support platform for medical cannabis, utilizing sensors, cloud-based algorithms, and a mobile app to analyze cannabis and personalize consumption recommendations.

When was Quana founded and by whom?

Quana was founded in April 2018 by co-founders Adi Naali and Zohar Kerem.

What is the total disclosed funding Quana has raised?

Quana has raised a total of $460K in a Seed round in July 2019.

What significant product development was noted in January 2020?

In January 2020, Quana was recognized for developing a unique olfactive device capable of detecting and analyzing cannabis samples without harming them.

What is Quana's operational status as of July 2025?

As of July 2025, Quana ceased to operate and is currently in a non-active status.